Skip Over Navigation Links
National Institutes of Health
:

Clinical Trials

Autism Spectrum Disorders (Pervasive Developmental Disorders)

Featured Studies

Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.

  • Minocycline to Treat Childhood Regressive Autism.
    Interventional study. There is a subgroup of children with autism that appears to develop typically for a period of time, and then loses social or language skills, or regresses. Ages 3-12. Locations in Washington, DC; Bethesda, MD.
  • Screening for Studies on Autism Spectrum Disorders.
    Evaluation study. This study will screen children and adolescents (and their parents) to determine the child's eligibility for participation in NIMH research studies on autism spectrum disorders, such as autism and Rett's Disorder. Ages 1 Year-20. Location in Bethesda, MD.
  • Long-Term Olanzapine Treatment in Children With Autism.
    Interventional study. This study will determine the short- and long-term safety and effectiveness of the drug olanzapine (Zyprexa®) for reducing symptoms of autism in children. Ages 3-12. Location in Philadelphia, PA.

Search ClinicalTrials.gov for other NIH studies on Autism Spectrum Disorders (Pervasive Developmental Disorders).